NIZORAL® Cream:
Packaging Update – effective from January 26, 2026
 
Vietnam – January 26, 2026 | As part of STADA Group’s global brand identity alignment and continued efforts to strengthen product recognition, STADA Vietnam Ltd., Co. (“STADA Vietnam”) – he official importer and distributor of some STADA products in Vietnam – would like to inform valued customers and business partners about the updated packaging design for the topical medication NIZORAL® Cream (Ketoconazole 2% w/w).
 
Starting from batch QJB2600 (Exprired date: 24/10/2028), the product will be circulated in the market with updated packaging as follows: 
 

 

>> Important notes:
  • During the transition period, products with both the current and updated packaging designs may continue to coexist in the market until existing inventory is fully depleted.
  • The packaging change does not affect the product’s quality, composition, formulation, indication, safety or therapeutic efficacy.
  • Products with the new packaging continue to be manufactured and strictly quality-controlled in accordance with the Group’s applicable standards.
 
>> The updated packaging maintains the same:
  • Pack size: Box of 01 tube × 15g cream
  • Registration No.: 540100991324
Please refer to the attached announcement below for further details regarding the packaging update. We aim to continue supporting you with greater convenience during the product consultation, distribution, and circulation process throughout the packaging transition period. 
 

STADA Vietnam sincerely appreciates the continued trust and support from healthcare professionals, customers, and business partners throughout this transition.